Nothing Special   »   [go: up one dir, main page]

DK0550020T3 - Monoklonale antistoffer mod human-igE - Google Patents

Monoklonale antistoffer mod human-igE

Info

Publication number
DK0550020T3
DK0550020T3 DK92121934.1T DK92121934T DK0550020T3 DK 0550020 T3 DK0550020 T3 DK 0550020T3 DK 92121934 T DK92121934 T DK 92121934T DK 0550020 T3 DK0550020 T3 DK 0550020T3
Authority
DK
Denmark
Prior art keywords
cir
ige
monoclonal antibodies
human
bind
Prior art date
Application number
DK92121934.1T
Other languages
English (en)
Inventor
Naohiro Washida
Toshiko Yoshida
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of DK0550020T3 publication Critical patent/DK0550020T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2/00Peptides of undefined number of amino acids; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK92121934.1T 1991-12-24 1992-12-23 Monoklonale antistoffer mod human-igE DK0550020T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP35700591A JP3156237B2 (ja) 1991-12-24 1991-12-24 抗ヒトIgE モノクローナル抗体

Publications (1)

Publication Number Publication Date
DK0550020T3 true DK0550020T3 (da) 1997-09-29

Family

ID=18451888

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92121934.1T DK0550020T3 (da) 1991-12-24 1992-12-23 Monoklonale antistoffer mod human-igE

Country Status (10)

Country Link
US (1) US5625039A (da)
EP (1) EP0550020B1 (da)
JP (1) JP3156237B2 (da)
KR (1) KR930012827A (da)
AT (1) ATE157401T1 (da)
CA (1) CA2086131C (da)
DE (1) DE69221845T2 (da)
DK (1) DK0550020T3 (da)
ES (1) ES2106815T3 (da)
ZA (1) ZA9210006B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020859A1 (en) * 1995-12-08 1997-06-12 Idexx Laboratories, Inc. Methods and compositions concerning allergy in dogs
US20030202980A1 (en) * 1995-12-29 2003-10-30 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
ZA971607B (en) * 1996-03-12 1998-08-25 Univ Johns Hopkins Methods of treatment of allergic diseases
US6060326A (en) * 1997-04-07 2000-05-09 Heska Corporation Method to detect canine IgE and kit therefor
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
WO1999038978A1 (en) * 1998-01-31 1999-08-05 University Of Arkansas Methods and reagents for decreasing allergic reactions
WO2000072879A1 (en) * 1999-05-26 2000-12-07 Tanox, Inc. TREATING ALLERGIC DISEASES WITH IMMUNOTHERAPY AND IgE ANTAGONISTS
WO2001014588A1 (en) * 1999-08-24 2001-03-01 Genaissance Pharmaceuticals, Inc. Drug target isogenes: polymorphisms in the immunoglobulin e receptor beta chain gene
WO2001051507A1 (fr) * 2000-01-14 2001-07-19 Daiichi Pharmaceutical Co., Ltd. Nouveau peptide et procede de criblage utilisant ledit peptide
US20050063994A1 (en) * 2000-04-06 2005-03-24 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
CA2403292C (en) 2000-04-06 2011-02-08 Panacea Pharmaceuticals, Llc Microbial delivery system
US6787524B2 (en) 2000-09-22 2004-09-07 Tanox, Inc. CpG oligonucleotides and related compounds for enhancing ADCC induced by anti-IgE antibodies
SE0101093D0 (sv) * 2001-03-28 2001-03-28 Pharmacia Diagnostics Ab Novel compound for treatment of allergy and asthma
EP2427497B1 (fr) 2009-05-07 2016-12-07 Stallergenes Utilisation d'immunoglobulines igg1 et/ou de ligands du récepteur cd32 pour le traitement de maladies et manifestations inflammatoires par voie mucosale

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
US4714759A (en) * 1985-12-02 1987-12-22 Whitaker Jr Robert B Immunotoxin therapy of allergy
US4940782A (en) * 1987-06-08 1990-07-10 G. D. Searle & Co. Monoclonal antibodies against IgE-associated determinants, hybrid cell lines producing these antibodies, and use therefore
JP2735196B2 (ja) * 1987-10-14 1998-04-02 イムネット アレルギーの免疫毒素治療
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
AU618317B2 (en) * 1987-12-31 1991-12-19 Tanox Biosystems, Inc. Unique antigenic epitopes on ige-bearing b lymphocytes
GB8910263D0 (en) * 1989-05-04 1989-06-21 Ciba Geigy Ag Monoclonal antibodies specific for an immunoglobulin isotype
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment

Also Published As

Publication number Publication date
KR930012827A (ko) 1993-07-21
DE69221845T2 (de) 1998-04-09
JP3156237B2 (ja) 2001-04-16
CA2086131A1 (en) 1993-06-25
ES2106815T3 (es) 1997-11-16
US5625039A (en) 1997-04-29
DE69221845D1 (de) 1997-10-02
ZA9210006B (en) 1993-06-29
EP0550020A2 (en) 1993-07-07
JPH05199895A (ja) 1993-08-10
ATE157401T1 (de) 1997-09-15
EP0550020B1 (en) 1997-08-27
EP0550020A3 (en) 1994-08-24
CA2086131C (en) 2003-05-13

Similar Documents

Publication Publication Date Title
DK0550020T3 (da) Monoklonale antistoffer mod human-igE
NO20210499A1 (no) Humanisert, glykoomkonstruert Type II anti-CD20 antistoff og anvendelse derav, samt vertscelle og farmasøytisk sammensetning
DK0502812T3 (da) Rekombinante antistoffer, som er specifikke for en vækstfaktorreceptor
DE122007000078I2 (de) CTL4A-Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendung
FI973120A0 (fi) Ihmisen gp39:n eri epitoopeille spesifisiä monoklonaalisia vasta-aineita ja menetelmiä niiden käyttämiseksi diagnosoinnissa ja terapiassa
DE69531679D1 (de) Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
DE69638355D1 (de) Anti-CD3-Antikörper zur Verwendung zur Induzierung von Immunsuppression
DE69309472D1 (de) Fusionsproteine von monomeren und dimeren von antikörperfragmenten
DE69429723D1 (de) Stressproteine und ihre verwendung
DE69233716D1 (de) Immunglobulinvarianten für spezifische Fc-epsilon Rezeptoren
DE69032979D1 (de) Bispezifische heteroantikörper mit zweifachen effektorfunktionen
ATE132197T1 (de) Monoklonale antikörper
KR880701108A (ko) 면역조절 조성물 및 이들의 용도
ES2072928T3 (es) Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular.
RU96109042A (ru) Рекомбинантные il4 антитела, используемые для лечения нарушений, связанных с действием il4
ATE314087T1 (de) Impfstoffe mit erhöhter wirkung basierend auf chimären immunoglobulin e peptiden
RU94046414A (ru) Моноклональные антитела к гликопротеину р, их получение и применение, продуцирующие их клетки, иммунологический диагностический набор на их основе, терапевтический состав
DK0749481T3 (da) Humaniserede monoklonale antistoffer mod human interleukin-4
ATE132162T1 (de) Humane gammainterferonantagonisten
DK1181366T3 (da) Mammale receptorproteiner, beslægtede reagenser og fremgangsmåder
ATE131069T1 (de) Composition comprising at least two different antibodies or fragments thereof.
ATE155042T1 (de) Warm-behandelte igm-antikörper-zusammensetzungen
PT524421E (pt) Herpesvirus humano tipo 6 proteina p 100, sequencias de adn correspondentes, preparacao e utilizacao
Cummings et al. Purification of human Fd'with anti-light chain antisera.